Modern Possibilities of Using Acotiamide in the Treatment of Functional Dyspepsia
Aim: to evaluate the efficacy and safety of the new prokinetic drug acotiamide in the treatment of functional dyspepsia.Key findings. Acotiamide is an antagonist of inhibitory muscarinic receptors of type 1 and 2 and a reversible inhibitor of acetylcholinesterase activity. In patients with functiona...
Main Authors: | A. A. Sheptulin, Yu. S. Rabotyagova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2024-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/845 |
Similar Items
-
Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review
by: Igor V. Maev, et al.
Published: (2023-10-01) -
Functional Dyspepsia and Gastroesophageal Reflux Disease: From Pathogenesis to Current Treatment Strategies
by: A. S. Trukhmanov, et al.
Published: (2024-12-01) -
Modern approaches to functional dyspepsia treatment
by: A. A. Sheptulin
Published: (2014-12-01) -
Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis
by: Qingqing Qi, et al.
Published: (2023-10-01) -
Modern aspects of the pathogenesis and treatment of dyspepsia
by: V. V. Tsukanov, et al.
Published: (2020-10-01)